| Andrew Campion |
and***********@nike.com
|
Nike, Inc. |
Managing Director of Strategic Business Ventures |
Accounting |
|
United States |
| Philip Knight |
phi**********@nike.com
|
Nike, Inc. |
Co-Founder & Chairman Emeritus |
Accounting |
|
United States |
| Johanna Nielsen |
joh************@nike.com
|
Nike, Inc. |
VP of Controlling & Principal Accounting Officer |
Accounting |
|
United States |
| Muge Dogan |
mug*******@nike.com
|
Nike, Inc. |
Chief Technology Officer |
Accounting |
|
United States |
| Paul Trussell |
pau**********@nike.com
|
Nike, Inc. |
VP of Investor Relations & Strategic Finance |
Accounting |
|
United States |
| Ann Miller |
ann*******@nike.com
|
Nike, Inc. |
Executive VP & Chief Legal Officer |
Accounting |
|
United States |
| Albert Bourla |
alb**********@pfizer.com
|
PFIZER INC |
Chairman of the Board & CEO |
Biotechnology: Pharmaceutical Preparations |
|
United States |
| David Denton |
dav*********@pfizer.com
|
PFIZER INC |
Chief Financial Officer & Executive VP |
Biotechnology: Pharmaceutical Preparations |
|
United States |
| Mikael Dolsten |
mik***********@pfizer.com
|
PFIZER INC |
Chief Scientific Officer and President of Research & Development |
Biotechnology: Pharmaceutical Preparations |
|
United States |
| Jennifer Damico |
jen************@pfizer.com
|
PFIZER INC |
Senior VP, Controller & Principal Accounting Officer |
Biotechnology: Pharmaceutical Preparations |
|
United States |